In consistent with our results, a growing number of studies have documented that the inhibition of LATS1 can result in the occurrence of colorectal cancer, gastric cancer, and renal cell carcinoma [29–31]. The gene discussed is LATS1; the disease is hereditary clear cell renal cell carcinoma.